People on the Move
Roche
Roche has announced it will replace the head of R&D for its biologics company Genetech.
Michael Varney (pictured), currently in charge of Small Molecule Drug Discovery, will take over from Richard Scheller at the end of the year when he retires as head of Genentech Research and Early Development (gRED).
Varney will also become a member of the enlarged Corporate Executive Committee of Roche.
Roche also announced two new members of its Board of Directors: Bernard Poussot, CEO of Wyeth, and Richard Lifton, director of the Yale Center for Human Genetics and Genomics.